-+ 0.00%
-+ 0.00%
-+ 0.00%

Neutra Corp's Neutra Life Sciences Expands 2026 Industry Conference Schedule to Deepen Sponsor and CRO Relationships Across Its Site Network

Barchart·09/14/2026 14:40:00
Listen to the news

HOUSTON, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Neutra Corp (OTC: NTRR), a company focused on health, wellness, and life sciences, today announced that its wholly owned clinical research Site Management Organization (SMO) subsidiary, Neutra Life Sciences (“NLS”), has expanded its 2026 industry conference schedule with the addition of three new events — Partnership with Sites, DPharm: Disruptive Innovations to Advance Clinical Trials, and Fall Clinical – Dermatology — as part of its ongoing strategy to deepen sponsor and CRO relationships and expand trial opportunities across its growing site network.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.